For example, Ranibizumab can target VEGFA and regulate the two pathways of hsa04151 and hsa05200 to play the role of immunomodulation after ischemic stroke, and may provide a basis for the following mechanism research. The gene discussed is VEGFA; the disease is ischemic stroke.